Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Axovant Sciences has spun out its small molecule team into a startup called Arvelle, which will develop an anti-epileptic drug after raising more than $100m in external funding.

Novartis and Johnson & Johnson have contributed to a series A round for Vor Biopharma, an oncology drug developer co-founded by PureTech Health.

Samsung Next and GreatPoint Ventures supplied series A capital for emergency response software provider RapidDeploy, which recently moved from South Africa to the US.

Egis Technology, TowerJazz, Meyer Corporation and Linear Dimensions have provided $13.2m for AI-in-sensor processor developer AIStorm.

LG Technology Ventures, BMW i Ventures and Toyota AI Ventures have contributed to a $22m round that increased the shuttle bus provider's total funding to $37m.

Citi Ventures took part in the consumer data analytics software provider's series A round, which will support expansion, hiring and product innovation.

Legend Capital has contributed to a $25m series A round for Mancando, which provides supply chain services for the automotive parts industry.

Six Fintech Ventures led a series A round consisting of debt and equity that included fellow corporate venturing units Berliner Volksbank Ventures and Credit Suisse Entrepreneur Capital.

The metastatic cancer drug developer has secured $60.8m from investors including Celgene and the WuXi AppTec-backed 6 Dimensions Capital.